(XP) Xp - Ratings and Ratios

Exchange: NASDAQ • Country: Cayman Islands • Currency: USD • Type: Common Stock • ISIN: KYG982391099

Brokerage, Investment, Funds, Loans, Insurance

Investment Banking & Brokerage
Market Cap in USD: 8,903m

IPO / Inception: 2019-12-11
12m vs SPY: 23.8%

EPS (Earnings per Share)

EPS CAGR: -45.02%
EPS Trend: -18.5%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 37.11%
Rev. Trend: 65.9%

Last SUE: -0.01
Qual. Beats: 0

Dividends

Dividend Yield	1.01%
Yield on Cost 5y	0.52%
Yield CAGR 5y	-62.93%
Payout Consistency	69.0%
Payout Ratio	1.9%

Risk via 5d forecast
Volatility	42.1%
Value at Risk 5%th	64.8%
Relative Tail Risk	-6.41%

Reward TTM
Sharpe Ratio	1.19
Alpha	37.96
CAGR/Max DD	0.09

Character TTM
Hurst Exponent	0.573
Beta	0.764
Beta Downside	0.625

Drawdowns 3y
Max DD	56.64%
Mean DD	24.77%
Median DD	26.89%

Description: XP Xp January 03, 2026

XP Inc. (NASDAQ: XP) is a Cayman-registered financial services platform that operates in Brazil, offering a broad suite of products-including brokerage, fixed-income, mutual and hedge funds, derivatives, credit cards, loans, insurance, real-estate funds, and wealth-management services-through an omni-channel network of online portals and physical branches.

Beyond retail brokerage, XP provides institutional services such as inter-dealer brokerage, issuer support, and commercial banking solutions (FX, deposits, and loan syndications), and it monetizes financial education via online and in-person courses.

Key recent metrics: FY 2023 revenue of roughly $1.4 billion, net income of $500 million, and assets under management (AUM) exceeding $150 billion, reflecting a 25 % YoY growth in the high-net-worth segment.

Sector drivers that shape XP’s outlook include Brazil’s expanding middle class, which fuels retail investing, and the country’s historically high interest rates that boost demand for fixed-income and credit products; however, macro volatility and regulatory changes remain material risks.

For a deeper quantitative view, you might explore XP’s metrics on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income (5.05b TTM) > 0 and > 6% of Revenue (6% = 1.05b TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA 3.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -205.3% (prev -62.02%; Δ -143.2pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.05 (>3.0%) and CFO 18.25b > Net Income 5.05b (YES >=105%, WARN >=100%)

Net Debt (60.09b) to EBITDA (4.56b) ratio: 13.18 <= 3.0 (WARN <= 3.5)

Current Ratio 0.82 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (534.9m) change vs 12m ago -2.02% (target <= -2.0% for YES)

Gross Margin 69.49% (prev 67.03%; Δ 2.46pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 4.90% (prev 5.47%; Δ -0.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 6.46 (EBITDA TTM 4.56b / Interest Expense TTM 690.8m) >= 6 (WARN >= 3)

Altman Z'' -0.42

(A) -0.09 = (Total Current Assets 164.85b - Total Current Liabilities 200.84b) / Total Assets 399.48b

(B) 0.01 = Retained Earnings (Balance) 3.87b / Total Assets 399.48b

(D) 0.05 = Book Value of Equity 19.17b / Total Liabilities 375.81b

Total Rating: -0.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 60.59

1. Piotroski 7.0pt

2. FCF Yield 43.20%

3. FCF Margin data missing

4. Debt/Equity 3.06

5. Debt/Ebitda 13.18

6. ROIC - WACC (= 0.80)%

7. RoE 23.23%

8. Rev. Trend 65.95%

9. EPS Trend -18.49%

What is the price of XP shares?

As of January 12, 2026, the stock is trading at USD 17.10 with a total of 5,686,530 shares traded.
Over the past week, the price has changed by +0.47%, over one month by -3.69%, over three months by +8.15% and over the past year by +49.54%.

Is XP a buy, sell or hold?

Xp has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy XP.

Strong Buy: 5
Buy: 5
Hold: 2
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the XP price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	23.5	37.3%
Analysts Target Price	23.5	37.3%
ValueRay Target Price	17.7	3.6%

XP Fundamental Data Overview January 10, 2026

Market Cap BRL = 47.82b (8.90b USD * 5.3713 USD.BRL)
P/E Trailing = 9.8057
P/E Forward = 8.9606
P/S = 0.5173
P/B = 2.0267
Beta = 1.196
Revenue TTM = 17.54b BRL
EBIT TTM = 4.46b BRL
EBITDA TTM = 4.56b BRL
Long Term Debt = 33.29b BRL (from longTermDebt, last fiscal year)
Short Term Debt = 72.51b BRL (from shortTermDebt, last quarter)
Debt = 72.51b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 60.09b BRL (from netDebt column, last quarter)
Enterprise Value = 41.52b BRL (47.82b + Debt 72.51b - CCE 78.81b)
Interest Coverage Ratio = 6.46 (Ebit TTM 4.46b / Interest Expense TTM 690.8m)
EV/FCF = 2.31x (Enterprise Value 41.52b / FCF TTM 17.93b)
FCF Yield = 43.20% (FCF TTM 17.93b / Enterprise Value 41.52b)
FCF Margin = 102.3% (FCF TTM 17.93b / Revenue TTM 17.54b)
Net Margin = 28.82% (Net Income TTM 5.05b / Revenue TTM 17.54b)
Gross Margin = 69.49% ((Revenue TTM 17.54b - Cost of Revenue TTM 5.35b) / Revenue TTM)
Gross Margin QoQ = 66.83% (prev 67.47%)
Tobins Q-Ratio = 0.10 (Enterprise Value 41.52b / Total Assets 399.48b)
Interest Expense / Debt = 0.20% (Interest Expense 142.0m / Debt 72.51b)
Taxrate = 0.04% (495.0k / 1.33b)
NOPAT = 4.46b (EBIT 4.46b * (1 - 0.04%))
Current Ratio = 0.82 (Total Current Assets 164.85b / Total Current Liabilities 200.84b)
Debt / Equity = 3.06 (Debt 72.51b / totalStockholderEquity, last quarter 23.66b)
Debt / EBITDA = 13.18 (Net Debt 60.09b / EBITDA 4.56b)
Debt / FCF = 3.35 (Net Debt 60.09b / FCF TTM 17.93b)
Total Stockholder Equity = 21.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.41% (Net Income 5.05b / Total Assets 399.48b)
RoE = 23.23% (Net Income TTM 5.05b / Total Stockholder Equity 21.75b)
RoCE = 8.11% (EBIT 4.46b / Capital Employed (Equity 21.75b + L.T.Debt 33.29b))
RoIC = 4.39% (NOPAT 4.46b / Invested Capital 101.67b)
WACC = 3.59% (E(47.82b)/V(120.33b) * Re(8.73%) + D(72.51b)/V(120.33b) * Rd(0.20%) * (1-Tc(0.00)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈12.25b ; Y1≈8.04b ; Y5≈3.67b
Fair Price DCF = 136.7 (EV 116.90b - Net Debt 60.09b = Equity 56.81b / Shares 415.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -18.49 | EPS CAGR: -45.02% | SUE: -4.0 | # QB: 0
Revenue Correlation: 65.95 | Revenue CAGR: 37.11% | SUE: -0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.40 | Chg30d=-0.040 | Revisions Net=-2 | Analysts=2
EPS next Year (2026-12-31): EPS=10.62 | Chg30d=+0.003 | Revisions Net=+3 | Growth EPS=+9.3% | Growth Revenue=+12.6%

Additional Sources for XP Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle